Table 1

Risk factors excluded from the Delphi questionnaire, including information to their origin

Excluded risk factors
Mentioned in only one of the selected publicationsHeart failure (L); liver disease (not hepatic impairment) (L); problems with ‘water works’ (L); antidepressant (L); drugs with positive inotrope effects (L), potassium channel activators (L); antibacterial drugs (L); laxatives (L); corticosteroids for inhalation (L), loperamide (L); statins (L); cephalosporins (L); compound analgesics (with opioids) (L); low-molecular-weight heparins (L); macrolide antibiotics (L); penicillin (L); aspirin (L); salbutamol (L); antihypertensives (L); bladder antimuscarinic drugs (L); cerebral vasodilators (L); nitroglycerine (L); ranitidine (L); 1st generation antihistamines (L)
Lowermost quartile of the NGT ranking list and not mentioned elsewhereMoney (N); Morbus Parkinson (N); xerostomia (N); oral bisphosphonate (N)
Seamless care issue or intervention to improve seamless care OR unpredictable event or circumstanceUnclear prescription/unclear or non-available dosage regimen at discharge (N); multiple treating physicians (L,N); missing instruction of relatives (N); medication-taking gap (N); briefing of the patient (L,Q); confusion of drug names (N); new medication/lots of changes/alternating dosages (N); changes in therapy: stop due to hospitalisation/discharge/generic medication (N,Q); unscheduled discharge (N)
Synonyms

  • Behaviour at home during an ADR (N); earlier experiences with medication (N,Q) → included as: experience with ADR (Q)

  • Impaired mobility (L,N) → included as: high risk of falls, motion insecurity (L,N,Q)

  • Language (Q) → included as: language issues (N)

  • Oral corticosteroid (L); systemic corticosteroids (L) → included as: corticosteroids (L)

  • Parallel therapy (N) →included as: self-medication with non-prescribed medicines (N,Q)

  • ADR, adverse drug reaction; L, literature search; N, NGT ranking list; NGT, nominal group technique; Q, qualitative analysis of the NGT.